Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 14.31
-0.16 (-1.11%)
May 18, 2026, 4:00 PM EDT
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 5.7 billion as of May 18, 2026. Its market cap has increased by 127.87% in one year.
Market Cap
5.70B
Enterprise Value
5.68B
Revenue
656.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.31
Market Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 5.70B, an increase of 137.31%. That is a compound annual growth rate of 22.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 5.70B | -41.35% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dian Diagnostics Group | 11.45B |
| Shanghai Runda Medical Technology | 7.99B |
| Amoy Diagnostics | 7.83B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 6.25B |
| Thalys Medical Technology Group | 4.47B |
| Shanghai Labway Clinical Laboratory | 4.24B |
| Guangdong Hybribio Biotech | 3.96B |